5-Hydroxymethylcytosine (5hmC) is a naturally occurring modified nucleobase found in DNA. Chemically, it is derived from the oxidation of 5-methylcytosine (5mC) at the methyl group, resulting in a hydroxymethyl substituent attached to the carbon‑5 position of the cytosine pyrimidine ring. The molecular formula is C₉H₁₃N₃O₅.
Biological occurrence
- 5hmC is present in the genomic DNA of a wide range of eukaryotic organisms, including mammals, zebrafish, and certain invertebrates. Its abundance varies among cell types and developmental stages, being particularly enriched in neuronal cells and embryonic stem cells.
- The modification is generated by the Ten‑Eleven Translocation (TET) family of Fe(II)/2‑oxoglutarate‑dependent dioxygenases (TET1, TET2, and TET3), which catalyze the stepwise oxidation of 5mC to 5hmC, and subsequently to 5‑formylcytosine and 5‑carboxylcytosine.
Functional significance
- 5hmC is considered an epigenetic mark that can influence gene expression. In many contexts, the presence of 5hmC correlates with active transcription and open chromatin states.
- It may serve as an intermediate in active DNA demethylation pathways. The removal of 5hmC can occur via base excision repair mechanisms, whereby the modified base is recognized and replaced with unmodified cytosine.
- Dysregulation of 5hmC levels has been associated with various diseases, most notably certain cancers and neurodevelopmental disorders, where altered TET activity leads to aberrant DNA methylation patterns.
Detection and analysis
- Conventional bisulfite sequencing does not distinguish between 5mC and 5hmC, as both resist deamination. Specialized methods have been developed to map 5hmC at single‑base resolution, including oxidative bisulfite sequencing (oxBS‑seq), Tet-assisted bisulfite sequencing (TAB‑seq), and antibody‑based enrichment approaches (hMeDIP‑seq).
- Quantitative measurement of global 5hmC levels can be performed using liquid chromatography–mass spectrometry (LC‑MS) or enzyme‑linked immunosorbent assays (ELISA) employing specific antibodies.
Historical background
- The existence of 5hmC in mammalian DNA was first reported in 2009 following the identification of TET enzymes and their catalytic activity. Subsequent studies have elucidated its distribution across the genome and its dynamic regulation during development and disease.
Research relevance
- Ongoing investigations aim to clarify the precise mechanisms by which 5hmC influences chromatin architecture, transcription factor binding, and genome stability.
- Therapeutic strategies targeting TET enzymes or the pathways governing 5hmC turnover are under exploration for potential interventions in cancer and epigenetic disorders.
